Parogrelil Hydrochloride

N/A

Report date: 2022/11/25 17:31:13
NME

Base Information

Drug NameParogrelil Hydrochloride
Drug Alias Nameparogrelilo帕罗格列parogrelilum帕洛格雷parogrelil +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitorsPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 3Phosphodiesterase 5A
Therapy Area/IndicationsPeripheral Vascular DiseasesIntermittent Claudication
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNissan Chemical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNissan Chemical CorpTaisho Pharmaceutical Co LtdNissan Chemical Industries Ltd
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesIntermittent Claudication

Other Information

ATC CodeN/A
Related LinksN/A